Publication | Closed Access

High-sensitivity C-reactive protein does not improve the differential diagnosis of HNF1A–MODY and familial young-onset type 2 diabetes: A grey zone analysis

Metabolic SyndromeDiabetes EpidemiologyDifferential DiagnosisDiabetesGenetic EpidemiologyInherited Metabolic DiseasePathologyGrey Zone AnalysisDiabetes ComplicationsBiomarker DiscoveryDiabetes MellitusHigh-sensitivity C-reactive ProteinMedicine